Knowles Julius - Insider Non-Derivative Transactions at Keros Therapeutics, Inc. (KROS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Apr 13, 2020, Knowles Julius's relationship to Keros Therapeutics, Inc. (KROS) is Director, and currently has 1,191 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KROS insiders.
Data Source: SEC.
Knowles Julius - Insider Non-Derivative Transactions at KROS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Apr 14, 2020 | P -- (Common Stock) | 1191 | 20.98 | 1191 |